Filings under ARCT by Arcturus Therapeutics Ltd. (CIK 0001566049) from Feb 7, 2019 to Feb 7, 2019 belong to a different issuer and are not shown. Filings under ARCT by American Realty Capital Trust, Inc. (CIK 0001410997) from Jan 22, 2008 to Jan 22, 2013 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Holmes Edward W | Director | Grant(A) | 15K | — | $0 |
| Jun 5, 2026 | Marantz Jing L. | Director | Grant(A) | 15K | — | $0 |
| Jun 5, 2026 | Marquet Magda | Director | Grant(A) | 15K | — | $0 |
| Jun 5, 2026 | Slaoui Moncef | Director | Grant(A) | 15K | — | $0 |
| Jun 5, 2026 | Markels John | Director | Grant(A) | 15K | — | $0 |
| Jun 5, 2026 | Barlow James F | Director | Grant(A) | 15K | — | $0 |
| Jun 5, 2026 | Farrell Peter C | Director | Grant(A) | 15K | — | $0 |
| May 1, 2026 | Mulroy Dennis | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Dec 17, 2025 | Kurata Lance | Chief Legal Officer | Grant(A) | 54K | — | $0 |
| Dec 17, 2025 | Payne Joseph E | President and CEO, Director | Grant(A) | 175K | — | $0 |
| Dec 17, 2025 | Chivukula Pad | Chief Scientific Officer & COO | Grant(A) | 54K | — | $0 |
| Dec 17, 2025 | Roberts Joseph | Controller | Grant(A) | 10K | — | $0 |
| Aug 15, 2025 | Sassine Andy | Chief Financial Officer, Director | Buy(P) | 1K | $16.56 | $21K |
| Jun 9, 2025 | Holmes Edward W | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2025 | Barlow James F | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2025 | Marantz Jing L. | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2025 | Markels John | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2025 | Marquet Magda | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2025 | Slaoui Moncef | Director | Grant(A) | 15K | — | $0 |
| Jun 9, 2025 | Farrell Peter C | Director | Grant(A) | 15K | — | $0 |
| Dec 16, 2024 | Sassine Andy | Chief Financial Officer, Director | Grant(A) | 60K | — | $0 |
| Dec 16, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Grant(A) | 60K | — | $0 |
| Dec 16, 2024 | Payne Joseph E | President and CEO, Director | Grant(A) | 196K | — | $0 |
| Dec 16, 2024 | Kurata Lance | Chief Legal Officer | Grant(A) | 60K | — | $0 |
| Oct 15, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 12K | $20.76 | $249K |
| Jun 19, 2024 | Slaoui Moncef | Director | Grant(A) | 15K | — | $0 |
| Jun 19, 2024 | Slaoui Moncef | Director | Grant(A) | 15K | — | $0 |
| Jun 14, 2024 | Farrell Peter C | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Farrell Peter C | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Farrell Peter C | Director | Grant(A) | 15K | — | $0 |
| Jun 14, 2024 | Barlow James F | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Barlow James F | Director | Grant(A) | 15K | — | $0 |
| Jun 14, 2024 | Barlow James F | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Marquet Magda | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Marquet Magda | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Marquet Magda | Director | Grant(A) | 15K | — | $0 |
| Jun 14, 2024 | Markels John | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Markels John | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Markels John | Director | Grant(A) | 15K | — | $0 |
| Jun 14, 2024 | Holmes Edward W | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Holmes Edward W | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Holmes Edward W | Director | Grant(A) | 15K | — | $0 |
| Jun 14, 2024 | Marantz Jing L. | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Marantz Jing L. | Director | Option exercise(M) | 3K | — | $0 |
| Jun 14, 2024 | Marantz Jing L. | Director | Grant(A) | 15K | — | $0 |
| Jun 12, 2024 | Sassine Andy | Chief Financial Officer, Director | Sell(S) | 50K | $32.03 | $1.6M |
| Jun 5, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 114 | $45.00 | $5K |
| Jun 3, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 26K | $40.01 | $1.0M |
| Mar 25, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 17K | $35.02 | $611K |
| Mar 19, 2024 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 9K | $35.01 | $300K |
| Dec 15, 2023 | Payne Joseph E | President and CEO, Director | Grant(A) | 200K | — | $0 |
| Dec 15, 2023 | Kummerfeld Keith C | See Remarks | Grant(A) | 30K | — | $0 |
| Dec 15, 2023 | Kurata Lance | Chief Legal Officer | Grant(A) | 75K | — | $0 |
| Dec 15, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Grant(A) | 125K | — | $0 |
| Dec 15, 2023 | Sassine Andy | Chief Financial Officer, Director | Grant(A) | 75K | — | $0 |
| Nov 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 5K | $18.72 | $94K |
| Oct 2, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 5K | $25.61 | $128K |
| Sep 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 5K | $31.45 | $157K |
| Aug 15, 2023 | Sassine Andy | Chief Financial Officer, Director | Grant(A) | 1K | $17.37 | $21K |
| Aug 1, 2023 | Marquet Magda | Director | Grant(A) | 3K | — | $0 |
| Aug 1, 2023 | Marquet Magda | Director | Grant(A) | 12K | — | $0 |
| Aug 1, 2023 | Barlow James F | Director | Grant(A) | 12K | — | $0 |
| Aug 1, 2023 | Barlow James F | Director | Grant(A) | 3K | — | $0 |
| Aug 1, 2023 | Holmes Edward W | Director | Grant(A) | 12K | — | $0 |
| Aug 1, 2023 | Holmes Edward W | Director | Grant(A) | 3K | — | $0 |
| Aug 1, 2023 | Marantz Jing L. | Director | Grant(A) | 12K | — | $0 |
| Aug 1, 2023 | Marantz Jing L. | Director | Grant(A) | 3K | — | $0 |
| Aug 1, 2023 | Farrell Peter C | Director | Grant(A) | 12K | — | $0 |
| Aug 1, 2023 | Farrell Peter C | Director | Grant(A) | 3K | — | $0 |
| Aug 1, 2023 | Markels John | Director | Grant(A) | 12K | — | $0 |
| Aug 1, 2023 | Markels John | Director | Grant(A) | 3K | — | $0 |
| Aug 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 5K | $34.91 | $175K |
| Jul 14, 2023 | Kummerfeld Keith C | See Remarks | Sell(S) | 7K | $35.00 | $244K |
| Jul 14, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 1K | $14.12 | $15K |
| Jul 14, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 5K | $9.04 | $41K |
| Jul 14, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 1K | $4.99 | $7K |
| Jul 14, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 1K | — | $0 |
| Jul 14, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 1K | — | $0 |
| Jul 14, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 5K | — | $0 |
| Jul 14, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 25K | $35.01 | $875K |
| Jul 3, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 5K | $28.75 | $144K |
| Jun 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 5K | $27.16 | $136K |
| May 11, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 8K | $30.24 | $240K |
| May 10, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 17K | $30.00 | $512K |
| May 1, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 5K | $25.93 | $130K |
| Apr 18, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 5K | $9.04 | $41K |
| Apr 18, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 1K | $4.99 | $7K |
| Apr 18, 2023 | Kummerfeld Keith C | See Remarks | Sell(S) | 7K | $28.18 | $196K |
| Apr 18, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 1K | $14.12 | $15K |
| Apr 17, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 5K | — | $0 |
| Apr 17, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 1K | — | $0 |
| Apr 17, 2023 | Kummerfeld Keith C | See Remarks | Option exercise(M) | 1K | — | $0 |
| Apr 3, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 5K | $25.38 | $127K |
| Mar 6, 2023 | Chivukula Pad | Chief Scientific Officer & COO | Sell(S) | 5K | $16.07 | $80K |
| Dec 15, 2022 | Marquet Magda | Director | Buy(P) | 2K | $18.00 | $40K |
| Dec 9, 2022 | Kurata Lance | Chief Legal Officer | Grant(A) | 125K | — | $0 |
| Dec 9, 2022 | Chivukula Pad | Chief Scientific Officer & COO | Grant(A) | 125K | — | $0 |
| Dec 9, 2022 | Payne Joseph E | President and CEO, Director | Grant(A) | 250K | — | $0 |
| Dec 9, 2022 | Sassine Andy | Chief Financial Officer, Director | Grant(A) | 125K | — | $0 |
| Dec 9, 2022 | Kummerfeld Keith C | See Remarks | Grant(A) | 40K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Arcturus Therapeutics Holdings Inc., SEC CIK 0001768224. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under ARCT and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for ARCT